drugset / Trial / NCT07131683
hUC-MSC-Exo Therapy for Autoimmune Encephalitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a phase I/IIa study to investigate the safety and preliminary efficacy of intranasal admnistration of human umbilical mesenchymal stem cell-derived exosome (hUC-MSC-Exo) for patients with autoimmune encephalitis.
Timeline
- Start
- 2025-11-01
- Primary completion
- 2027-06-30
- Completion
- 2027-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes | Other / unclassified | 2.5e+10 unknown | Intranasal |
| Subject | Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes | Other / unclassified | 5e+10 unknown | Intranasal |
| Subject | Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes | Other / unclassified | 1e+11 unknown | Intranasal |